Remote monitoring of cardiac implantable devices during COVID-19 outbreak: "keep people safe" and "focus only on health care needs".
COVID-19
Cardiac implantable electronic device
remote monitoring
telemedicine
Journal
Acta cardiologica
ISSN: 1784-973X
Titre abrégé: Acta Cardiol
Pays: England
ID NLM: 0370570
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
19
11
2020
medline:
20
5
2021
entrez:
18
11
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic has challenged the ability of health care organisations to provide adequate care. We report the experience of a national tertiary electrophysiology centre in the management of patients with cardiac implantable electronic devices (CIEDs) through the use of a fully remote follow-up model. We daily and prospectively collected remote monitoring (RM) relevant findings and following clinical actions performed from March 10 During the study period (25 days), we received 2,215 transmissions from 2,955 devices. Among them, 129 patients reported potential clinically actionable RM observations (event rate: 12.0/1000 patient-week). In 77 patients (60%), RM events triggered a clinical action, but only 5 patients needed an urgent in-hospital access (4 urgent procedures and 1 device reprogramming). In the unprecedented COVID-19 pandemic, RM became an essential tool in healthcare delivery for CIED patients. We observed that RM was effective in "keep people safe" and "focus only on individuals with health care needs".
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic has challenged the ability of health care organisations to provide adequate care. We report the experience of a national tertiary electrophysiology centre in the management of patients with cardiac implantable electronic devices (CIEDs) through the use of a fully remote follow-up model.
METHODS
METHODS
We daily and prospectively collected remote monitoring (RM) relevant findings and following clinical actions performed from March 10
RESULTS
RESULTS
During the study period (25 days), we received 2,215 transmissions from 2,955 devices. Among them, 129 patients reported potential clinically actionable RM observations (event rate: 12.0/1000 patient-week). In 77 patients (60%), RM events triggered a clinical action, but only 5 patients needed an urgent in-hospital access (4 urgent procedures and 1 device reprogramming).
CONCLUSIONS
CONCLUSIONS
In the unprecedented COVID-19 pandemic, RM became an essential tool in healthcare delivery for CIED patients. We observed that RM was effective in "keep people safe" and "focus only on individuals with health care needs".
Identifiants
pubmed: 33203312
doi: 10.1080/00015385.2020.1847459
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM